Abstract
Tianhao Gao, Robert C. Smith, Suzhen Zhang, Zhaolin Zhai, Chang Lu, Yuke Dong, Kaiming Zhuo, Qiong Xiang, Jinhong Wang, Hua Jin, John M. Davis, Yifeng Xu, Kaida Jiang, Dengtang Liu
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Modulation of GABA and resting state functional connectivity by transcranial direct current stimulation
10.7554/elife.08789 · 2015
Anatomical correlate of positive spontaneous visual phenomena: a voxelwise lesion study
10.1212/wnl.0b013e3181cb3e64 · 2010
GABA and glutamate in the preterm neonatal brain: In-vivo measurement by magnetic resonance spectroscopy
10.1016/j.neuroimage.2021.118215 · 2021
Unresolved referenced work
1911
Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
10.1017/s0033291719002277 · 2020
The trajectory of prefrontal GABA levels in initially antipsychotic-naïve patients with psychosis during 2 years of treatment and associations with striatal cerebral blood flow and outcome
2024
Heterogeneity and homogeneity of regional brain structure in schizophrenia: a meta-analysis
10.1001/jamapsychiatry.2017.2663 · 2017
1H magnetic resonance spectroscopy to understand the biological basis of ALS, diagnose patients earlier, and monitor disease progression
2021
Clinical predictors of therapeutic response to antipsychotics in schizophrenia
10.31887/dcns.2014.16.4/mcarbon · 2014
Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients
10.1016/j.biopsych.2017.09.028 · 2018
Baseline GABA concentration and fMRI response
10.1016/j.neuroimage.2010.07.017 · 2010
Orientation discrimination performance is predicted by GABA concentration and gamma oscillation frequency in human primary visual cortex
10.1523/jneurosci.4426-09.2009 · 2009
Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre (1)H-MRS study (OPTiMiSE)
10.1038/s41380-018-0082-9 · 2018
Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia
10.1016/j.nicl.2014.03.014 · 2014
Regulation of cerebral microvessels by glutamatergic mechanisms
10.1016/s0006-8993(97)00040-1 · 1997
Functional connectivity in the brain--is it an elusive concept?
10.1016/j.neubiorev.2004.10.009 · 2005
Review of functional and anatomical brain connectivity findings in schizophrenia
10.1097/yco.0b013e32835d9e6a · 2013
The dysconnection hypothesis (2016)
10.1016/j.schres.2016.07.014 · 2016
The role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia
10.2174/1381612819666131216114612 · 2014
Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA study
10.1038/s41537-022-00265-5 · 2022
Brain lateralization: a comparative perspective
10.1152/physrev.00006.2019 · 2020
Cognitive control network connectivity differentially disrupted in treatment resistant schizophrenia
10.1016/j.nicl.2021.102631 · 2021
Cortical control of aggression: GABA signalling in the anterior cingulate cortex
10.1016/j.euroneuro.2017.12.007 · 2020
The positive and negative syndrome scale (PANSS) for schizophrenia
10.1093/schbul/13.2.261 · 1987
The group of treatment resistant schizophrenias. Heterogeneity in treatment resistant schizophrenia (TRS)
10.3389/fpsyt.2018.00757 · 2018
Resting-state brain activity in schizophrenia and major depression: a quantitative meta-analysis
10.1093/schbul/sbr151 · 2013
Frontal GABA in schizophrenia: a meta-analysis of (1)H-MRS studies
10.1080/15622975.2020.1731925 · 2021
What does the PANSS mean?
10.1016/j.schres.2005.04.008 · 2005
Definitions of response and remission in schizophrenia: recommendations for their use and their presentation
10.1111/j.1600-0447.2008.01308.x · 2009
Anterior cingulate GABA and glutamate concentrations are associated with resting-state network connectivity
10.1038/s41598-018-38078-1 · 2019
Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI
10.1016/j.schres.2007.09.006 · 2008
Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: a global-brain functional connectivity analysis
10.1016/j.schres.2019.09.003 · 2020
Anterior cingulate cortex glutamate levels are related to response to initial antipsychotic treatment in drug-naive first-episode schizophrenia patients
2020
Brain-wide analysis of functional connectivity in first-episode and chronic stages of schizophrenia
2017
Neurometabolic and functional changes of default-mode network relate to clinical recovery in first-episode psychosis patients: a longitudinal (1)H-MRS and fMRI study
10.1016/j.nicl.2022.102970 · 2022
Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: rationale and trial design
10.1016/j.schres.2020.11.010 · 2021
Clozapine after 1 failed antipsychotic drug trial in first-episode psychosis: a randomized clinical trial
10.1001/jamapsychiatry.2026.0086 · 2026
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
10.1056/nejmoa051688 · 2005
Glutamate and dysconnection in the salience network: neurochemical, effective connectivity, and computational evidence in schizophrenia
10.1016/j.biopsych.2020.01.021 · 2020
Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?
10.1016/j.conb.2011.10.018 · 2012
Neurofunctional correlates of glutamate and GABA imbalance in psychosis: a systematic review
10.1016/j.neubiorev.2022.105010 · doi-reference
The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: a (1)H-MRS study in first-episode psychosis patients
10.3389/fpsyt.2022.967941 · doi-reference
Gamma-aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy ((1) H-MRS) study
10.1111/pcn.13463 · doi-reference
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
10.1006/nimg.2001.0978 · doi-reference
Developmental and regional changes in the neurochemical profile of the rat brain determined by in vivo 1H NMR spectroscopy
10.1002/mrm.10497 · doi-reference
Modulators of GABA(A) receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
10.1038/s41386-023-01728-8 · doi-reference
GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study
10.1016/j.schres.2009.11.011 · doi-reference
Selective role of lingual/parahippocampal gyrus and retrosplenial complex in spatial memory across viewpoint changes relative to the environmental reference frame
10.1016/j.bbr.2012.12.031 · doi-reference
Heterogeneity of treatment effects in schizophrenia
10.1016/j.amjmed.2007.02.005 · doi-reference
Anterior cingulate glutamate and GABA associations on functional connectivity in schizophrenia
10.1093/schbul/sby075 · doi-reference
Influence of glutamate and GABA transport on brain excitatory/inhibitory balance
10.1177/1535370221989263 · doi-reference
Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review
10.1176/appi.ajp.2015.14101329 · doi-reference
7T proton magnetic resonance spectroscopy of the anterior cingulate cortex in first-episode schizophrenia
10.1093/schbul/sbx190 · doi-reference
Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia
10.1016/j.biopsych.2010.04.013 · doi-reference
Glutamate and glutamine: a review of in vivo MRS in the human brain
10.1002/nbm.3045 · doi-reference
GABA(A) receptors in visual and auditory cortex and neural activity changes during basic visual stimulation
10.3389/fnhum.2012.00337 · doi-reference
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
10.1038/s41537-019-0090-z · doi-reference
Neuroimaging studies of cognitive function in schizophrenia
10.1007/978-3-030-05542-4_6 · doi-reference
A multimodal neuroimaging study investigating resting-state connectivity, glutamate and GABA at 7 T in first-episode psychosis
10.1503/jpn.210107 · doi-reference
Individual variability in the shape and amplitude of the BOLD-HRF correlates with endogenous GABAergic inhibition
10.1002/hbm.21223 · doi-reference
Towards a consensus regarding global signal regression for resting state functional connectivity MRI
10.1016/j.neuroimage.2016.11.052 · doi-reference
Contribution of excitatory and inhibitory neuronal activity to BOLD fMRI
10.1093/cercor/bhab068 · doi-reference
Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis
10.1017/s0033291721004128 · doi-reference
(1)H-MRS and MEGA-PRESS pulse sequence in the study of balance of inhibitory and excitatory neurotransmitters in the human brain of ultra-high risk of schizophrenia patients
10.1134/s1607672916030029 · doi-reference
Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls
10.1038/s41398-021-01455-y · doi-reference
Atypical functional connectivity in resting-state networks of individuals with 22q11.2 deletion syndrome: associations with neurocognitive and psychiatric functioning
10.1186/s11689-016-9135-z · doi-reference
Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?
10.1016/j.conb.2011.10.018 · doi-reference
Glutamate and dysconnection in the salience network: neurochemical, effective connectivity, and computational evidence in schizophrenia
10.1016/j.biopsych.2020.01.021 · doi-reference
GABA and glutamate in the human brain
10.1177/1073858402238515 · doi-reference
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
10.1056/nejmoa051688 · doi-reference
Clozapine after 1 failed antipsychotic drug trial in first-episode psychosis: a randomized clinical trial
10.1001/jamapsychiatry.2026.0086 · doi-reference
Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: rationale and trial design
10.1016/j.schres.2020.11.010 · doi-reference
Neurometabolic and functional changes of default-mode network relate to clinical recovery in first-episode psychosis patients: a longitudinal (1)H-MRS and fMRI study
10.1016/j.nicl.2022.102970 · doi-reference
Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: a global-brain functional connectivity analysis
10.1016/j.schres.2019.09.003 · doi-reference
Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI
10.1016/j.schres.2007.09.006 · doi-reference
Anterior cingulate GABA and glutamate concentrations are associated with resting-state network connectivity
10.1038/s41598-018-38078-1 · doi-reference
Definitions of response and remission in schizophrenia: recommendations for their use and their presentation
10.1111/j.1600-0447.2008.01308.x · doi-reference
What does the PANSS mean?
10.1016/j.schres.2005.04.008 · doi-reference
Frontal GABA in schizophrenia: a meta-analysis of (1)H-MRS studies
10.1080/15622975.2020.1731925 · doi-reference
Resting-state brain activity in schizophrenia and major depression: a quantitative meta-analysis
10.1093/schbul/sbr151 · doi-reference